Integer Corporation (ITGR)
NYSE: ITGR
· Real-Time Price · USD
101.49
-0.28 (-0.28%)
At close: Sep 26, 2025, 3:59 PM
101.50
0.01%
After-hours: Sep 26, 2025, 05:52 PM EDT
Integer Revenue Breakdown
| Period Ending | Jun 27, 2025 | Mar 28, 2025 | Dec 31, 2024 | Sep 27, 2024 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 |
|---|---|---|---|---|---|---|---|
| Cardiac Rhythm Management & Neuromodulation Revenue | 172M | 160.34M | 495.52M | 165.09M | 148.27M | 144.22M | 133.65M |
| Cardiac Rhythm Management & Neuromodulation Revenue Growth | +7.27% | -67.64% | +200.14% | +11.34% | +2.81% | +7.91% | n/a |
| Cardio And Vascular Revenue | 286.86M | 258.87M | 708.57M | 241.01M | n/a | n/a | n/a |
| Cardio And Vascular Revenue Growth | +10.81% | -63.47% | +194.00% | n/a | n/a | n/a | n/a |
| Other Markets Revenue | 17.64M | 18.18M | n/a | 25.31M | n/a | n/a | n/a |
| Other Markets Revenue Growth | -2.94% | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 | Oct 3, 2014 | Jul 4, 2014 | Jan 3, 2014 | Sep 27, 2013 | Jun 28, 2013 | Mar 29, 2013 | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belgium Revenue | 16.24M | 14.26M | 20.49M | 18.17M | 16.86M | 12.3M | 16.02M | 17.37M | 33.94M | 13.72M | 17.65M | 13.77M | 39.11M | 37.66M | 23.23M | 53.51M | 26.32M | 28.11M |
| Belgium Revenue Growth | +13.89% | -30.43% | +12.80% | +7.77% | +36.98% | -23.18% | -7.77% | -48.82% | +147.31% | -22.25% | +28.20% | -64.80% | +3.85% | +62.15% | -56.59% | +103.34% | -6.37% | n/a |
| Puerto Rico Revenue | 39.03M | 41.74M | 39.34M | 39.13M | 38.65M | 26.82M | 37.41M | 34.02M | 61.24M | 34.58M | 31.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Puerto Rico Revenue Growth | -6.51% | +6.10% | +0.55% | +1.23% | +44.13% | -28.33% | +9.99% | -44.45% | +77.08% | +8.46% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue | 111.46M | 83.9M | 84.46M | 72.82M | 77.78M | 35.97M | 46.42M | 39.42M | 90.39M | 47.07M | 44.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue Growth | +32.85% | -0.66% | +15.98% | -6.38% | +116.24% | -22.50% | +17.74% | -56.39% | +92.04% | +5.09% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 192.87M | 206.66M | 204.09M | 202.12M | 184.28M | 71.55M | 75.04M | 70.52M | 158.45M | 76.33M | 77.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -6.68% | +1.26% | +0.97% | +9.68% | +157.57% | -4.66% | +6.42% | -55.50% | +107.58% | -1.84% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 27, 2025 | Mar 28, 2025 | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 52.92M | 38.89M | 47.47M | 33.85M | 37.13M | 37.84M | 45.8M | 42.1M | 45.83M | 41.89M | 41.04M | 38.2M | 41.79M | 39.56M | 36.27M | 34.27M | 35.38M | 35.5M | 35.04M | 3.61M | 33.9M | 36.46M | 37.66M | 32.94M | 33.14M | 34.96M | 35.14M | 34.09M | 36.78M | 41.24M | 42.62M | 39.73M | 39.72M | 39.5M | 37.51M | 36.27M | 37.63M | 41.89M | 33.51M | 22.31M | 24.1M | 22.61M | 24.85M |
| Selling, General, and Administrative Revenue Growth | +36.09% | -18.07% | +40.21% | -8.81% | -1.89% | -17.38% | +8.79% | -8.13% | +9.41% | +2.07% | +7.44% | -8.59% | +5.63% | +9.08% | +5.83% | -3.14% | -0.35% | +1.33% | +870.82% | -89.35% | -7.01% | -3.20% | +14.35% | -0.63% | -5.19% | -0.53% | +3.08% | -7.31% | -10.81% | -3.24% | +7.26% | +0.02% | +0.57% | +5.30% | +3.43% | -3.62% | -10.17% | +25.01% | +50.21% | -7.45% | +6.61% | -9.01% | n/a |
| Research and Development Revenue | 14.24M | 14.2M | 10.61M | 11.92M | 16.1M | 15.75M | 13.26M | 14.54M | 16.88M | 19.09M | 13.84M | 16.12M | 14.87M | 16.08M | 12.74M | 12.05M | 13.74M | 13.46M | 10.59M | 11.89M | 12.75M | 13.24M | 11.81M | 11.73M | 11.4M | 11.6M | 10.16M | 12.23M | 12.94M | 14.54M | 15.34M | 13.61M | 12.89M | 13.41M | 12.64M | 11.41M | 13.64M | 17.31M | 13.09M | 14.3M | 13.06M | 12.54M | 9.88M |
| Research and Development Revenue Growth | +0.27% | +33.79% | -10.98% | -25.96% | +2.23% | +18.83% | -8.82% | -13.88% | -11.57% | +37.94% | -14.15% | +8.42% | -7.54% | +26.28% | +5.69% | -12.29% | +2.06% | +27.12% | -10.96% | -6.70% | -3.74% | +12.13% | +0.68% | +2.92% | -1.72% | +14.14% | -16.96% | -5.42% | -11.03% | -5.23% | +12.74% | +5.57% | -3.89% | +6.07% | +10.79% | -16.33% | -21.18% | +32.23% | -8.47% | +9.46% | +4.13% | +26.94% | n/a |